Quest Diagnostics (DGX) Tops Q4 EPS by 4c; Guides In-Line
Tweet
Share
E-mail
Get Alerts DGX Hot Sheet
Price: $194.35 -0.33%
Revenue Growth %: +8.0%
Financial Fact:
Total operating costs and expenses: 1.56B
Today's EPS Names:
OCCI, MAYS, CRMT, More
Revenue Growth %: +8.0%
Financial Fact:
Total operating costs and expenses: 1.56B
Today's EPS Names:
OCCI, MAYS, CRMT, More
Join SI Premium – FREE
Quest Diagnostics (NYSE: DGX) reported Q4 EPS of $1.31, $0.04 better than the analyst estimate of $1.27. Revenue for the quarter came in at $1.86 billion versus the consensus estimate of $1.86 billion.
GUIDANCE:
Quest Diagnostics sees FY2017 EPS of $5.37-$5.52, versus the consensus of $5.45. Quest Diagnostics sees FY2017 revenue of $7.64-7.72 billion, versus the consensus of $7.66 billion.
For earnings history and earnings-related data on Quest Diagnostics (DGX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ennis (EBF) Reports In-Line Q1 EPS
- Robinhood plans $2B convertible notes offering due 2029
- AeroVironment restates quarterly financials, citing $89M goodwill error
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
